Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by 30secondson May 10, 2017 9:29am

148 Views

Post# 26224988

called and left msg, you should too.

To get NHS shares from NF, a shareholder must have already owned shares on or before the Share Distribution Record Date of November 30, 2016... At best NF will hand out the shares late in first quarter of 2017... The First quarters end of 2017 looks to be March or Jan... https://newagefarminc.com/new-age-farm-provides-update-regarding-the-plan-of-arrangement-with-nhs-industries-ltd/ Further infomation needed? Contact below: Catherine Jones Corporate Communications corpcom@newagefarminc.com (888) 871-3936 Everyone bombard this company with phone calls and emails regarding our NHS shares untill NF provides a news release...

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment